Timing matters: tacrolimus intra-patient variability within the initial seven months forecasts <i>de novo</i> DSA and subsequent rejection in a Chinese kidney transplant cohort.

Front Immunol · 2026 · PMC13199030 · PMID 42199410

Europe PMC DOI

hedged sentences

0.3300

closest p · 6.6× alpha

0.3300

boldest claim

The sentences

did not reach statistical significanceP = 0.33not close (p > 0.1)

3.75%), this difference did not reach statistical significance ( P = 0.33).

also in 75,281 other papers

a numerical trendno p-value reported

3.75%, P = 0.33), although a numerical trend toward a higher incidence was observed in the dnDSA-positive cohort ( Figure 5C ). 4.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Timing matters: tacrolimus intra-patient variability within the initial seven months forecasts &lt;i&gt;de novo&lt;/i&gt; DSA and subsequent rejection in a Chinese kidney transplant cohort.

The sentences

Timing matters: tacrolimus intra-patient variability within the initial seven months forecasts <i>de novo</i> DSA and subsequent rejection in a Chinese kidney transplant cohort.